India Pharma Outlook Team | Friday, 27 February 2026
LTM, a top business creativity partner for global enterprises, has secured a seven-year strategic agreement worth $100 million with a leading European MedTech company known for its innovative hearing solutions.
The partnership will focus on product development, digital support, and compliance management for the company’s flagship hearing instruments and related applications.
Through this deal, LTM will deploy its advanced iNXT platform, a cutting-edge solution designed for digital transformation across industries. The platform will enhance product development, streamline operations, and improve user experiences for both wearable hearing devices and accompanying mobile apps.
Also Read: Bridging Collaboration Gaps to Boost India's Pharma Discovery
The collaboration will also involve supporting the MedTech company’s core hearing instrument brands, private-label products, and fitting applications for hearing care professionals. Additionally, LTM will manage complex regulatory compliance in the MedTech sector, ensuring the products meet both global and local standards.
“We are excited to extend our collaboration into the MedTech space through this strategic partnership,” said LTM spokesperson. “By combining our iNXT platform capabilities with deep domain expertise, we are committed to supporting our client in delivering innovative, reliable, and compliant hearing solutions that improve patient outcomes and professional workflows.”
This partnership strengthens LTM’s role as a global leader in business transformation, leveraging human insights and intelligent systems to drive measurable value and support clients in regulated industries.
